Biodexa Pharmaceuticals Stock (NASDAQ: BDRX) stock price, news, charts, stock research, profile.
You can purchase shares of Biodexa Pharmaceuticals (NASDAQ:BDRX) through any online brokerage.
Other companies in Biodexa Pharmaceuticals’s space includes: Fortress Biotech (NASDAQ:FBIO), Gain Therapeutics (NASDAQ:GANX), FibroGen (NASDAQ:FGEN), Armata Pharmaceuticals (AMEX:ARMP) and Inovio Pharmaceuticals (NASDAQ:INO).
Biodexa Pharmaceuticals has a consensus price target of $8.00.
The stock price for Biodexa Pharmaceuticals (NASDAQ: BDRX) is $4.2 last updated January 2, 2025 at 4:46 PM EST.
There are no upcoming dividends for Biodexa Pharmaceuticals.
Biodexa Pharmaceuticals’s H1 earnings are confirmed for Tuesday, January 14, 2025.
There is no upcoming split for Biodexa Pharmaceuticals.
Biodexa Pharmaceuticals is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.